Seventure Partners
Investor profile
Investment firmVenture capital
Seventure Partners has backed 95 European tech companies across 116 funding rounds between 2004 and 2026, joining rounds totalling €1.8B. Most active in Healthtech and Software. Data as of 4 Nov 2026.
Also recorded as: Seventure
Deals
116
distinct rounds
Companies
95
backed
Active span
2004–2026
23 yrs
Total round €
€1.8B
sum of rounds joined
Deals by year
distinct rounds / yearSeventure Partners — deals by year — interactive chart.
Data table
| Seventure Partners — deals by year | |
|---|---|
| 2004 | 1 |
| 2005 | 3 |
| 2007 | 2 |
| 2008 | 1 |
| 2009 | 4 |
| 2010 | 6 |
| 2011 | 3 |
| 2012 | 3 |
| 2013 | 5 |
| 2014 | 5 |
| 2015 | 5 |
| 2016 | 13 |
| 2017 | 13 |
| 2018 | 7 |
| 2019 | 1 |
| 2020 | 2 |
| 2021 | 6 |
| 2022 | 9 |
| 2023 | 7 |
| 2024 | 7 |
| 2025 | 6 |
| 2026 | 7 |
Top sectors
by dealsSeventure Partners — top sectors — interactive chart.
Data table
| Seventure Partners — top sectors | |
|---|---|
| Healthtech | 35 |
| Software | 27 |
| Fintech | 14 |
| Marketing | 7 |
| Media | 6 |
| Foodtech | 5 |
| Wellness & Beauty | 4 |
| HRtech | 4 |
| Cybersecurity | 4 |
| Sports | 3 |
Stages
by dealsSeventure Partners — stages — interactive chart.
Data table
| Seventure Partners — stages | |
|---|---|
| Series A | 30 |
| Other | 26 |
| Series B | 24 |
| Early VC | 17 |
| Series C | 9 |
| Seed | 8 |
| Growth/Late | 1 |
| Series D+ | 1 |
Countries
by dealsSeventure Partners — countries — interactive chart.
Data table
| Seventure Partners — countries | |
|---|---|
| France | 63 |
| Germany | 24 |
| UK | 8 |
| Ireland | 4 |
| Israel | 4 |
| Netherlands | 4 |
| Belgium | 2 |
| Spain | 2 |
| Czech Republic | 1 |
| Denmark | 1 |
Co-investment network
shared roundsCo-investment network — interactive chart.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
Frequent co-investors
shared rounds- Bpifrance8
- btov Partners6
- XAnge5
- Andera Partners4
- Johnson & Johnson4
- Sofinnova Partners4
- 360 Capital Partners3
- Alven Capital3
- Astanor Ventures3
- Bayern Kapital3
- Big Idea Ventures3
- Dumont Venture3
- Gilde Healthcare3
- GIMV3
- Good Startup3
- High-Tech Gründerfonds (HTGF)3
- Lightstone Ventures3
- Medtronic3
- Novo Holdings3
- Technologiegründerfonds Sachsen (TGFS)3
- Adelie Capital2
- Bel Group2
- BioGeneration Ventures2
- Bleu Capital2
- Boehringer Ingelheim Venture Fund2
Portfolio
top 30 by total round €| Company | Country | Rounds | Total € |
|---|---|---|---|
| Tubulis Technologies | Germany | 2 | €368M |
| Fire1 | Ireland | 3 | €179M |
| Citryll | Netherlands | 2 | €104M |
| Microbiotica | UK | 2 | €103M |
| Galecto Biotech | Denmark | 1 | €79M |
| BiomX | Israel | 2 | €50M |
| Flexvelop | Germany | 2 | €47M |
| Standing Ovation | France | 3 | €46M |
| Eligo Bioscience | France | 2 | €44M |
| Abalos Therapeutics | Germany | 1 | €43M |
| Domain Therapeutics | France | 1 | €40M |
| Sekoia.io | France | 1 | €35M |
| Quanta Fluid Solutions | UK | 1 | €34M |
| bsport | Spain | 1 | €30M |
| YesWeHack | France | 1 | €26M |
| La Vie | France | 1 | €25M |
| Sunrise | Belgium | 1 | €25M |
| Push Doctor | UK | 1 | €22M |
| VoluBill | France | 2 | €21M |
| DayTwo | Israel | 2 | €21M |
| Glopal | France | 1 | €20M |
| ID5 | UK | 1 | €18M |
| Expensya | France | 1 | €17M |
| Hackuity | France | 1 | €16M |
| E-Blink | France | 3 | €16M |
| Corwave | France | 1 | €16M |
| STUDITEMPS GmbH | Germany | 3 | €15M |
| Kebony | Norway | 1 | €15M |
| EspaceMax | France | 1 | €13M |
| Dopavision | Germany | 1 | €12M |
Biggest deals
top 10 by amount| Company | Stage | Amount | Date |
|---|---|---|---|
| Tubulis Technologies | Series C | €308M | 2025-10 |
| Fire1 | Other | €115M | 2025-01 |
| Citryll | Series B | €85M | 2024-12 |
| Galecto Biotech | Series C | €79M | 2018-10 |
| Microbiotica | Series B | €61M | 2022-03 |
| Tubulis Technologies | Series B | €60M | 2022-05 |
| Flexvelop | Other | €44M | 2025-03 |
| Abalos Therapeutics | Series A | €43M | 2021-10 |
| Fire1 | Series C | €40M | 2018-01 |
| Domain Therapeutics | Series A | €40M | 2022-05 |